Inclusion Criteria:

- Histologically proved epithelial ovarian cancer (serous, mucinous, clear cell,
endometrioid, undifferentiated type)

- Recurrence of anytime necessitating a new line of chemotherapy

- Patient having received adjuvant chemotherapy

- Informed consent signed prior any study specific procedures

Exclusion Criteria:

- More than 3 lines of chemotherapy

- Pregnancy or breastfeeding

- History of other cancers within the past 5 years (except curatively treated
non-melanoma skin cancer and in situ cervical cancer)

- Psychological, social, geographical disorders or any other condition that would
preclude study compliance (treatment modalities and study follow-up).